Pathophysiology and pathogenic mechanisms of pulmonary hypertension: role of membrane receptors, ion channels, and Ca2+ signaling

A Balistrieri, A Makino, JXJ Yuan - Physiological reviews, 2023 - journals.physiology.org
The pulmonary circulation is a low-resistance, low-pressure, and high-compliance system
that allows the lungs to receive the entire cardiac output. Pulmonary arterial pressure is a …

Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies

H Christou, RA Khalil - American Journal of Physiology …, 2022 - journals.physiology.org
Pulmonary hypertension (PH) is a serious disease characterized by various degrees of
pulmonary vasoconstriction and progressive fibroproliferative remodeling and inflammation …

ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis

YM Kim, SJ Kim, R Tatsunami… - … of Physiology-Cell …, 2017 - journals.physiology.org
Reactive oxygen species (ROS) derived from NADPH oxidase (NOX) and mitochondria play
a critical role in growth factor-induced switch from a quiescent to an angiogenic phenotype …

Endothelial HIF-2α contributes to severe pulmonary hypertension due to endothelial-to-mesenchymal transition

H Tang, A Babicheva, KM McDermott… - … of Physiology-Lung …, 2018 - journals.physiology.org
Pulmonary vascular remodeling characterized by concentric wall thickening and intraluminal
obliteration is a major contributor to the elevated pulmonary vascular resistance in patients …

International union of basic and clinical pharmacology. CVIII. Calcium-sensing receptor nomenclature, pharmacology, and function

K Leach, FM Hannan, TM Josephs, AN Keller… - Pharmacological …, 2020 - Elsevier
The calcium-sensing receptor (CaSR) is a class CG protein–coupled receptor that responds
to multiple endogenous agonists and allosteric modulators, including divalent and trivalent …

Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease

YS Prakash - American Journal of Physiology-Lung Cellular …, 2016 - journals.physiology.org
Airway structure and function are key aspects of normal lung development, growth, and
aging, as well as of lung responses to the environment and the pathophysiology of important …

TRPC6, a therapeutic target for pulmonary hypertension

PP Jain, N Lai, M **ong, J Chen… - … of Physiology-Lung …, 2021 - journals.physiology.org
Idiopathic pulmonary arterial hypertension (PAH) is a fatal and progressive disease.
Sustained vasoconstriction due to pulmonary arterial smooth muscle cell (PASMC) …

Mitochondrial dysfunction and pulmonary hypertension: cause, effect, or both

JD Marshall, I Bazan, Y Zhang… - American Journal of …, 2018 - journals.physiology.org
Pulmonary hypertension describes a heterogeneous disease defined by increased
pulmonary artery pressures, and progressive increase in pulmonary vascular resistance due …

Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation

J Chen, M Rodriguez, J Miao, J Liao… - … of Physiology-Lung …, 2022 - journals.physiology.org
Concentric pulmonary vascular wall thickening due partially to increased pulmonary artery
(PA) smooth muscle cell (PASMC) proliferation contributes to elevating pulmonary vascular …

[HTML][HTML] mTOR signaling in pulmonary vascular disease: pathogenic role and therapeutic target

A Babicheva, A Makino, JXJ Yuan - International journal of molecular …, 2021 - mdpi.com
Pulmonary arterial hypertension (PAH) is a progressive and fatal disease without a cure.
The exact pathogenic mechanisms of PAH are complex and poorly understood, yet a …